OpGen Inc (LTS:0A8L)
$ 5.087 0 (0%) Market Cap: 4.87 Mil Enterprise Value: 17.13 Mil PE Ratio: 0 PB Ratio: 1.72 GF Score: 36/100

Q3 2019 OpGen Inc Earnings Call Transcript

Nov 06, 2019 / 09:30PM GMT
Operator

Welcome to the OpGen Third Quarter 2019 Earnings Call and Business Update. (Operator Instructions)

As a reminder, this conference is being recorded today, November 6, 2019. Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen and Curetis N.V.

I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K and 10-Q, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Factors that may affect the company's results include, but are not limited to: the completion of the business combination with Curetis N.V.; pursuit of FDA clearance for the Acuitas AMR Gene Panel for use with bacterial isolates; the use of proceeds from the October 2019 public offering; activities related to the company's products and services; the rate of adoption of its products and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot